RJ Bio-Tech Financials

BSE: 536456

₹3.43

₹0.02 (0.59%)

As on 01-Apr-2024IST

Market cap

₹3 Cr

Revenue (TTM)

₹14 Cr

P/E Ratio

--

P/B Ratio

--

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
Operating Revenue	13.90	15.80	13.36	10.12	8.85	15.73
Total Income	14.57	15.80	13.47	10.25	8.99	15.73
Total Expenditure	12.58	28.42	16.84	17.49	16.84	26.99
EBITDA	1.32	-12.62	-3.48	-7.38	-8.00	-11.27
Depreciation	0.07	0.09	0.10	0.15	0.19	0.21
EBIT	1.25	-12.71	-3.58	-7.53	-8.19	-11.47
Interest	5.82	0.00	0.78	4.14	3.89	3.60
Other Income	0.67	--	0.11	0.13	0.14	0.00
Exceptional Items	-0.15	-2.97	0.09	0.00	-8.83	0.06
Profit before Tax	-4.05	-15.68	-4.16	-11.53	-20.77	-15.02
Provision for Tax	--	--	--	--	--	0.00
Profit after Tax	-4.05	-15.68	-4.16	-11.53	-20.77	-15.02

Liabilities (₹ Cr)	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
Shareholder's Funds	-50.34	-41.18	-25.50	-21.34	-9.81	10.95
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.91	4.34	5.87	5.92	5.85	2.31
Current Liabilities	48.35	42.71	45.04	43.21	39.04	34.27
Total Liabilities	1.92	5.86	25.41	27.78	35.08	47.53

Assets (₹ Cr)	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
Non-Current Assets	1.63	2.23	2.22	2.41	2.50	2.66
Current Assets	0.29	3.63	22.10	24.34	31.50	43.51
Total Assets	1.92	5.86	25.41	27.78	35.08	47.53
Total Debt*	50.64	40.29	41.85	41.27	37.12	29.63
Net Current Assets	-48.06	-39.08	-22.94	-18.87	-7.53	9.24
Contingent Liabilities	0.87	0.88	0.89	0.00	0.93	1.04

Cashflow (₹ Cr)	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
Cash From Operating Activities	-4.72	1.96	0.71	0.84	-2.69	0.07
Cash Flow from Investing Activities	--	-0.37	-0.67	-0.77	-0.82	-0.84
Cash from Financing Activities	4.68	-1.54	-0.06	-0.03	3.45	0.82
Net Cash Inflow / Outflow	-0.04	0.05	-0.02	0.04	-0.05	0.05

Financials Ratios	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
Adjusted EPS (₹)	-4.28	-16.56	-4.39	-12.18	-21.93	-15.86
Cash EPS (₹)	-4.21	-16.47	-4.29	-12.02	-21.74	-15.64
Adjusted Book Value (₹)	-53.17	-43.50	-28.10	-23.63	-11.50	10.13
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-4.98	2.07	0.75	0.89	-2.84	0.07
Free Cash Flow per Share (₹)	-6.29	-2.63	-0.89	-4.35	-8.21	-5.12

Profitability Ratios	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
ROCE (%)	--	-218.35	-19.75	-32.76	-51.57	-25.86
ROE (%)	--	--	--	--	--	-88.93
ROA (%)	-104.09	-100.28	-15.63	-36.69	-50.28	-27.96
EBIT Margin (%)	8.98	-80.46	-26.79	-74.43	-92.54	-72.95
Net Margin (%)	-27.79	-99.28	-30.85	-112.49	-231.08	-95.48
Cash Profit Margin (%)	-28.65	-98.70	-30.33	-112.50	-231.55	-94.11

Growth Ratios	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
Revenue Growth (%)	-12.02	18.24	32.06	14.35	-43.75	-56.26
EBIT Growth (%)	109.82	-255.10	52.46	8.03	28.64	-300.64
Net Profit Growth (%)	74.18	-277.31	63.95	44.47	-38.29	-761.74
EPS Growth (%)	74.18	-277.31	63.95	44.47	-38.29	-761.75
Book Value Growth (%)	-22.24	-54.82	-18.88	-105.57	-213.49	-60.34

Valuation Ratios	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	-0.10	-0.15	-0.46	-0.82	-2.13	2.47
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	27.91	-3.69	-16.05	-8.22	-7.68	-4.73
Close Price (₹)	5.17	6.73	12.90	19.30	24.50	25.00
High Price (₹)	11.95	15.75	20.10	19.60	32.00	45.00
Low Price (₹)	5.12	5.05	12.90	19.30	12.45	20.00
Market Cap (₹ Cr)	4.89	6.37	12.21	18.27	23.20	23.67

Solvency Ratios	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
Debt to Equity	-1.01	-0.98	-1.57	-1.84	-3.41	3.09
Short term debt to equity ratio	-0.93	-0.88	-1.42	-1.66	-3.20	2.52
Current Ratio	0.01	0.09	0.49	0.56	0.81	1.27
Quick Ratio	0.01	0.06	0.17	0.25	0.46	0.58
Interest Coverage	0.30	-6,943.08	-4.30	-1.79	-4.34	-3.17

Operating Efficiency Ratios	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12
Debtors to sales (%)	1.99	5.25	55.16	99.05	188.07	120.66
Asset Turnover	3.57	1.01	0.50	0.32	0.22	0.29
Receivable days	14.52	94.72	237.13	480.92	731.32	497.38
Inventory Days	--	179.09	380.60	491.48	761.77	617.29
Payable days	18.67	40.89	161.00	173.18	122.42	63.66
Cash Conversion Cycle	-4.15	232.92	456.73	799.22	1,370.67	1,051.01